Feedback

Feedback PEG

The PEG Ratio (Price/Earnings-to-Growth) of Feedback (FDBK.L) as of Nov 4, 2026 is -0.01.

PEG

-0.01

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Feedback is 2025 -0.01 . PEG Ratio (Price/Earnings-to-Growth) of Feedback was 2024 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Feedback Stock analysis

What does Feedback do? Feedback PLC provides imaging tools for clinical decision makers, including TexRAD for medical research and clinical trial management, and Cadran for medical imaging decision support. The company offers Cadran Image Storage Management for image display, review, and enterprise archiving across clinical, non-clinical, and teaching environments. Subsidiaries such as Feedback Black Box Company Limited, Feedback Data GmbH, Brickshield Limited, Cambridge Computed Imaging Limited, TexRAD Limited, and Prostate Checker Ltd support its operations. The firm generates revenue through these products and services targeting medical practitioners, researchers, and pharmaceutical companies involved in cancer detection and treatment workflows. TexRAD is utilized by pharmaceutical companies for managing clinical trials and research, while Cadran and Cadran Image Storage Management are sold to healthcare providers and institutions requiring advanced imaging solutions. The company’s focus on imaging biomarkers for cancer detection attracts partnerships with medical research organizations and hospitals seeking to improve diagnostic accuracy and patient outcomes. Feedback Data GmbH and TexRAD Limited specifically contribute to the development and management of imaging techniques and workflow solutions for the medical sector. The business model centers on selling specialized imaging software and tools to healthcare institutions, pharmaceutical firms, and research organizations. Products like Cadran Image Storage Management are designed for enterprise-level archiving and image handling, appealing to large healthcare systems and academic institutions. TexRAD’s role in clinical trial management ensures recurring revenue streams from pharmaceutical clients who rely on its platform for trial execution and data management. Feedback is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Feedback stock

PEG Ratio (Price/Earnings-to-Growth) of Feedback is -0.01 in 2025.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Feedback since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Feedback with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Feedback

All Key Metrics — Feedback